2m 2m 2m 2m 2m 2m 2m
Charlotte-Unty (CWBHF)
OTC
$0.35+$0.02 (+6.23%)
Price as of Sep 11, 2026- $94.1MMarket Cap
- 243.90%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Charlotte-Unty (CWBHF)
$0.35+$0.02 (+6.23%)
CWBHF | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.35 | ||
Change | +$0.02 (+6.23%) | ||
Open | $0.29 | ||
High | $0.35 | ||
Low | $0.29 | ||
Previous Close | $0.33 | ||
Volume | 195,934 | ||
30-Day Average Volume | 265,774 | ||
1-Week Change | 8.44% | ||
1-Month Change | 25.72% | ||
1-Year Change | 243.90% | ||
3-Year Change | -5.83% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 271.3M | ||
Total Assets | $76.4M | ||
Market Cap | $94.1M | ||
Enterprise Value | $80.2M | ||
Period: QTR TTM FY | |||
Revenue | $10.9M | ||
Net Income | -$4.1M | ||
Free Cash Flow | -$955,000.00 | ||
EBIT | -$3.2M | ||
EBITDA | -$1.7M | ||
Net Working Capital | $26.3M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | -48 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 2 | ||
P/E | -17 | ||
PEG | -0 | ||
Price/Free Cash Flow | -99 | ||
Price/Operating Cash Flow | -102 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue